Vimarsana
Biggest News Aggregation in the World

Page 3 - Term Safety News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Term Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Term Safety Today - Breaking & Trending Today

Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1 - Vimarsana News

Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1

VEVYE® is the First and Only Cyclosporine-Based Product Indicated for the Treatment of Both Signs and Symptoms of Dry Eye Disease with Efficacy Demonstrated After Four WeeksVEVYE® is the Only Water-Free Ophthalmic Product with Convenient Twice-Daily (BID) DosingNASHVILLE, Tenn. & HEIDELBERG, Germany--(BUSINESS WIRE)...

John Harsh, PhD: Interim Results Show Once-Nightly ON-SXB Dose is Preferred by Patients - Vimarsana News

John Harsh, PhD: Interim Results Show Once-Nightly ON-SXB Dose is Preferred by Patients

Patients participating in the open-label extension trial had a few months for titration, more than 24 months for stable dosing, and a one-week follow up.

Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ at SLEEP 2023 - Vimarsana News

Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ at SLEEP 2023

– 12 accepted abstracts highlight Company’s emerging leadership in narcolepsy – – Data adds to growing body of evidence demonstrating positive clinical benefit and patient... | June 10, 2023

Denver School board includes gender education in safety plan to prevent shootings - Vimarsana News

Denver School board includes gender education in safety plan to prevent shootings

The Denver school board’s newly released draft "Long-Term Safety Plan" will allow individual schools to decide whether to use school resource officers, so that way politicians won’t have to take responsibility for violent events like the recent shootings. Afterall, it’s an election year and Auon’ta

Novaliq Announces Presentation of New Scientific Data on CyclASol 0.1% (Cyclosporine Ophthalmic Solution) at the American Society of Cataract and Refractive Surgery Annual Meeting - Vimarsana News

Novaliq Announces Presentation of New Scientific Data on CyclASol 0.1% (Cyclosporine Ophthalmic Solution) at the American Society of Cataract and Refractive Surgery Annual Meeting

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the presentation of new data on the investigational